Drug-induced catalepsy as influenced by psychostimulants, apomorphine, L-dopa, and yohimbine.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D002375:Catalepsy / Q000139:chemically induced*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D006213:Hallucinogens / Q000494:pharmacology*; D006220:Haloperidol / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D009538:Nicotine / Q000037:antagonists & inhibitors; D010261:Paraoxon / Q000037:antagonists & inhibitors; D010393:Pempidine / Q000494:pharmacology; D010633:Phenmetrazine / Q000494:pharmacology; D010862:Pilocarpine / Q000037:antagonists & inhibitors; D013034:Sparteine / Q000494:pharmacology; D013747:Tetrabenazine / Q000037:antagonists & inhibitors; D014268:Trifluoperazine / Q000037:antagonists & inhibitors; D015016:Yohimbine / Q000494:pharmacology*
D006213:Hallucinogens; D010862:Pilocarpine; D014268:Trifluoperazine; D013034:Sparteine; D015016:Yohimbine; D004295:Dihydroxyphenylalanine; D008464:Mecamylamine; D009538:Nicotine; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D010393:Pempidine; D010261:Paraoxon; D010633:Phenmetrazine; D013747:Tetrabenazine